MedPath

Mobile Technology and Motivational Interviewing in Type 2 Diabetes Patients

Not Applicable
Completed
Conditions
Gaming
Quality of Life
Mobile Technology
Type 2 Diabetes Mellitus
Motivational Interviewing
Self-Management
Interventions
Behavioral: Patient Education with Game-Based Mobile Technology and Motivational Interviewing
Registration Number
NCT05919706
Lead Sponsor
Inonu University
Brief Summary

Type 2 diabetes patients were divided into experimental and control groups. Patients in the control group received regular nursing care, while those in the experimental group received MI, which is empowered by game-based mobile technology. Pre-test, post-test and follow-up test self-management, quality of life and satisfaction levels scores were determined.

Detailed Description

A randomized controlled and experimental study design was used to conduct this research on 64 patients with Type 2 DM. Purpose of this study was to explore how motivational interviewing powered by game-based mobile technology affected self-management, quality of life, and satisfaction in Type 2 diabetes patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Being 18 years or older,
  • Having a diagnosis of Type 2 Diabetes Mellitus according to the ADA diagnostic criteria,
  • Being on oral antidiabetic and/or insulin therapy,
  • Having a smart phone and knowing how to use it,
  • Internet connection (to install mobile technology application),
  • Not having participated in motivational interviewing (MG) training before,
  • Not having vision and hearing problems,
  • Not having a communication problem,
  • To be able to read, write and speak Turkish,
  • Volunteering to participate in the study and continue the study process.
Exclusion Criteria
  • Having a diagnosis of Type 1 and/or Gestational Diabetes Mellitus,
  • Having serious health problems that prevent participation in motivational interviewing,
  • Using steroid therapy,
  • Having complications that may develop in the long term due to diabetes and having advanced retinopathy, neuropathy, amputation history or active foot wound,
  • Having mental confusion, having any psychiatric problems and/or using a psychiatric drug,
  • Being unwilling to participate in the study and/or not wanting to continue the study process.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental GroupPatient Education with Game-Based Mobile Technology and Motivational InterviewingPre-test data were collected from patients with Patient Information and Follow-up Form, Diabetes Self-Management Scale (DSMQ) and Short Form-36 Quality of Life Scale (SF-36). After the pre-test, a educational program and a game-based mobile technology application were carried out for 4 weeks, 2 days a week at intervals. After the educational program were completed, motivational interviews were conducted once a week for 4 weeks. In this process, it was ensured that the game-based mobile technology application continued. Post-test data were collected with DSMQ and SF-36 at 2 months (8 weeks after the pre-test). After the post-test, the patients were followed up for 4 weeks. After the follow, with the Patient Information and Follow-up Form, DSMQ, SF-36, and the Satisfaction Questionnaire the follow-test data was collected.
Primary Outcome Measures
NameTimeMethod
DSMQLast 8 weeks

The scale is of a four-point Likert type. The scale has 4 sub-dimensions as "Glucose Management, Diet Control, Physical Activity, Health-Care Use" and a total score. The lowest score of the scale is 0 points and the highest score is 10 points. The higher the score, the higher the diabetes self-management.

SF-36Last 4 weeks

The scale consists of 36 items and 8 sub-dimensions. 8 sub-dimensions have 2 summary sub-dimensions as "Physical Health and Mental Health". There is no total score in the scale. A score between 0-100 is evaluated with sub-dimensions (0: Poor Health, 100: Good Health). Low scores on the scale indicate poor health, while high scores indicate good health.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bingol State Hospital

🇹🇷

Bingöl, Centrer, Turkey

© Copyright 2025. All Rights Reserved by MedPath